Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
4. Cancer colorectal métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Table 1 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Metachronous pulmonary and pancreatic metastases arising from sigmoid colon cancer: A case report
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial - ScienceDirect
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results | British Journal of Cancer
The prognostic effect of adjuvant chemotherapy in the colon cancer patients with solitary lymph node metastasis | International Journal of Colorectal Disease
Kaplan–Meier curves of patients with stage III colon cancer in right-... | Download Scientific Diagram
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Adjuvant Therapy for Locoregional Colon Cancer (Slides With Transcript)
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study - Annals of Oncology
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient
JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Oral adjuvant therapy for colorectal cancer: recent developments and future targets | Therapeutic Delivery
IJMS | Free Full-Text | Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
